Jul 30, 2020 4:05pm EDT OPKO Health Reports 2020 Second Quarter Business Highlights and Financial Results
Jul 20, 2020 2:45pm EDT OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)
Jul 13, 2020 8:00am EDT OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees
Jul 09, 2020 8:00am EDT Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees
Jul 01, 2020 8:15am EDT OPKO Health's BioReference Laboratories Reports Results of COVID-19 Testing for Almost One Quarter of a Million Nursing Home and Live-in Facility Employees
Jun 09, 2020 8:00am EDT OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency
Jun 01, 2020 8:00am EDT FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients